APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Polysomnography (Psg) System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ambulatory Polysomnography (Psg) System Market Outlook and Growth Opportunities 2026

22 January 2026192 pages

Choose your research edition.

Industry ResearchAmbulatory Polysomnography (Psg) System Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Polysomnography (Psg) System Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Ambulatory Polysomnography (Psg) System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Polysomnography (Psg) System Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambulatory Polysomnography (Psg) System Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ambulatory Polysomnography (Psg) System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ambulatory Polysomnography (Psg) System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ambulatory Polysomnography (Psg) System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ambulatory Polysomnography (Psg) System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ambulatory Polysomnography (Psg) System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ambulatory Polysomnography (Psg) System market include Natus Embla, Compumedics, Neurosoft, Cadwell Industries, Philips, Löwenstein Medical, Nihon Kohden, Nox Medical and Somnomedics AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ambulatory Polysomnography (Psg) System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ambulatory Polysomnography (Psg) System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ambulatory Polysomnography (Psg) System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ambulatory Polysomnography (Psg) System market.

Ambulatory Polysomnography (Psg) System Segment by Company

Natus Embla

Compumedics

Neurosoft

Cadwell Industries

Philips

Löwenstein Medical

Nihon Kohden

Nox Medical

Somnomedics AG

Advanced Brain Monitoring (ABM)

DEYMED Diagnostic

Hangzhou NeuroTrace

Beijing BMC Medical

Hunan VentMed Medical Technology

Hangzhou Lucky Day Medical Technology

Ambulatory Polysomnography (Psg) System Segment by Type

＜10-Channel

≥10-Channel

Ambulatory Polysomnography (Psg) System Segment by Application

Hospital

Home

Others

Ambulatory Polysomnography (Psg) System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ambulatory Polysomnography (Psg) System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ambulatory Polysomnography (Psg) System key companies, revenue, market share, and recent developments.

3. To split the Ambulatory Polysomnography (Psg) System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ambulatory Polysomnography (Psg) System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ambulatory Polysomnography (Psg) System significant trends, drivers, influence factors in global and regions.

6. To analyze Ambulatory Polysomnography (Psg) System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Polysomnography (Psg) System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Polysomnography (Psg) System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Polysomnography (Psg) System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambulatory Polysomnography (Psg) System industry.

Chapter 3: Detailed analysis of Ambulatory Polysomnography (Psg) System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ambulatory Polysomnography (Psg) System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ambulatory Polysomnography (Psg) System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ambulatory Polysomnography (Psg) System Industry Trends Table 2. Ambulatory Polysomnography (Psg) System Industry Drivers Table 3. Ambulatory Polysomnography (Psg) System Industry Opportunities and Challenges Table 4. Ambulatory Polysomnography (Psg) System Industry Restraints Table 5. Global Ambulatory Polysomnography (Psg) System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ambulatory Polysomnography (Psg) System Revenue Share by Company (2021-2026) Table 7. Global Ambulatory Polysomnography (Psg) System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ambulatory Polysomnography (Psg) System Key Company Manufacturing Base & Headquarters Table 9. Global Ambulatory Polysomnography (Psg) System Company, Product Type & Application Table 10. Global Ambulatory Polysomnography (Psg) System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ambulatory Polysomnography (Psg) System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ＜10-Channel Table 15. Significant Companies of ≥10-Channel Table 16. Global Ambulatory Polysomnography (Psg) System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ambulatory Polysomnography (Psg) System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Ambulatory Polysomnography (Psg) System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Type (2021-2026) Table 20. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Home Table 23. Significant Companies of Others Table 24. Global Ambulatory Polysomnography (Psg) System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ambulatory Polysomnography (Psg) System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Ambulatory Polysomnography (Psg) System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Application (2021-2026) Table 28. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Application (2027-2032) Table 29. Global Ambulatory Polysomnography (Psg) System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Ambulatory Polysomnography (Psg) System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Region (2021-2026) Table 32. Global Ambulatory Polysomnography (Psg) System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Region (2027-2032) Table 34. Global Ambulatory Polysomnography (Psg) System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Ambulatory Polysomnography (Psg) System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Ambulatory Polysomnography (Psg) System Sales Value Market Share by Country (2021-2026) Table 37. Global Ambulatory Polysomnography (Psg) System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Ambulatory Polysomnography (Psg) System Sales Value Market Share by Country (2027-2032) Table 39. Natus Embla Company Information Table 40. Natus Embla Business Overview Table 41. Natus Embla Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Natus Embla Ambulatory Polysomnography (Psg) System Product Portfolio Table 43. Natus Embla Recent Development Table 44. Compumedics Company Information Table 45. Compumedics Business Overview Table 46. Compumedics Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Compumedics Ambulatory Polysomnography (Psg) System Product Portfolio Table 48. Compumedics Recent Development Table 49. Neurosoft Company Information Table 50. Neurosoft Business Overview Table 51. Neurosoft Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Neurosoft Ambulatory Polysomnography (Psg) System Product Portfolio Table 53. Neurosoft Recent Development Table 54. Cadwell Industries Company Information Table 55. Cadwell Industries Business Overview Table 56. Cadwell Industries Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Cadwell Industries Ambulatory Polysomnography (Psg) System Product Portfolio Table 58. Cadwell Industries Recent Development Table 59. Philips Company Information Table 60. Philips Business Overview Table 61. Philips Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Philips Ambulatory Polysomnography (Psg) System Product Portfolio Table 63. Philips Recent Development Table 64. Löwenstein Medical Company Information Table 65. Löwenstein Medical Business Overview Table 66. Löwenstein Medical Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Löwenstein Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 68. Löwenstein Medical Recent Development Table 69. Nihon Kohden Company Information Table 70. Nihon Kohden Business Overview Table 71. Nihon Kohden Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nihon Kohden Ambulatory Polysomnography (Psg) System Product Portfolio Table 73. Nihon Kohden Recent Development Table 74. Nox Medical Company Information Table 75. Nox Medical Business Overview Table 76. Nox Medical Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nox Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 78. Nox Medical Recent Development Table 79. Somnomedics AG Company Information Table 80. Somnomedics AG Business Overview Table 81. Somnomedics AG Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Somnomedics AG Ambulatory Polysomnography (Psg) System Product Portfolio Table 83. Somnomedics AG Recent Development Table 84. Advanced Brain Monitoring (ABM) Company Information Table 85. Advanced Brain Monitoring (ABM) Business Overview Table 86. Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Product Portfolio Table 88. Advanced Brain Monitoring (ABM) Recent Development Table 89. DEYMED Diagnostic Company Information Table 90. DEYMED Diagnostic Business Overview Table 91. DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Product Portfolio Table 93. DEYMED Diagnostic Recent Development Table 94. Hangzhou NeuroTrace Company Information Table 95. Hangzhou NeuroTrace Business Overview Table 96. Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Product Portfolio Table 98. Hangzhou NeuroTrace Recent Development Table 99. Beijing BMC Medical Company Information Table 100. Beijing BMC Medical Business Overview Table 101. Beijing BMC Medical Ambulatory Polysomnography (Psg) System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Beijing BMC Medical Ambulatory Polysomnography (Psg) System Product Portfolio Table 103. Beijing BMC Medical Recent Development Table 104. Hunan VentMed Medical Technology Company Information Table 105. Hunan VentMed Medical Technology Business Overview Table 106. Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio Table 108. Hunan VentMed Medical Technology Recent Development Table 109. Hangzhou Lucky Day Medical Technology Company Information Table 110. Hangzhou Lucky Day Medical Technology Business Overview Table 111. Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio Table 113. Hangzhou Lucky Day Medical Technology Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Ambulatory Polysomnography (Psg) System Product Image Figure 2. Global Ambulatory Polysomnography (Psg) System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Polysomnography (Psg) System Market Size (2021-2032) & (US$ Million) Figure 4. Global Ambulatory Polysomnography (Psg) System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ＜10-Channel Image Figure 8. ≥10-Channel Image Figure 9. Global Ambulatory Polysomnography (Psg) System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Ambulatory Polysomnography (Psg) System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Home Image Figure 14. Others Image Figure 15. Global Ambulatory Polysomnography (Psg) System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ambulatory Polysomnography (Psg) System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Application (2021-2032) Figure 18. Global Ambulatory Polysomnography (Psg) System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Ambulatory Polysomnography (Psg) System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Ambulatory Polysomnography (Psg) System Sales Value (2021-2032) & (US$ Million) Figure 21. North America Ambulatory Polysomnography (Psg) System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Ambulatory Polysomnography (Psg) System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Ambulatory Polysomnography (Psg) System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Ambulatory Polysomnography (Psg) System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Ambulatory Polysomnography (Psg) System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Ambulatory Polysomnography (Psg) System Sales Value (2021-2032) & (US$ Million) Figure 27. South America Ambulatory Polysomnography (Psg) System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Ambulatory Polysomnography (Psg) System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Ambulatory Polysomnography (Psg) System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • ＜10-Channel
  • ≥10-Channel
Applications
  • Hospital
  • Home
  • Others
Companies covered
  • Natus Embla
  • Compumedics
  • Neurosoft
  • Cadwell Industries
  • Philips
  • Löwenstein Medical
  • Nihon Kohden
  • Nox Medical
  • Somnomedics AG
  • Advanced Brain Monitoring (ABM)
  • DEYMED Diagnostic
  • Hangzhou NeuroTrace
  • Beijing BMC Medical
  • Hunan VentMed Medical Technology
  • Hangzhou Lucky Day Medical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ambulatory Polysomnography (Psg) System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ambulatory Polysomnography (Psg) System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ambulatory Polysomnography (Psg) System Market Dynamics
  1. 2.1 Ambulatory Polysomnography (Psg) System Industry Trends
  2. 2.2 Ambulatory Polysomnography (Psg) System Industry Drivers
  3. 2.3 Ambulatory Polysomnography (Psg) System Industry Opportunities and Challenges
  4. 2.4 Ambulatory Polysomnography (Psg) System Industry Restraints
3 Ambulatory Polysomnography (Psg) System Market by Company
  1. 3.1 Global Ambulatory Polysomnography (Psg) System Company Revenue Ranking in 2025
  2. 3.2 Global Ambulatory Polysomnography (Psg) System Revenue by Company (2021-2026)
  3. 3.3 Global Ambulatory Polysomnography (Psg) System Company Ranking (2024-2026)
  4. 3.4 Global Ambulatory Polysomnography (Psg) System Company Manufacturing Base and Headquarters
  5. 3.5 Global Ambulatory Polysomnography (Psg) System Company Product Type and Application
  6. 3.6 Global Ambulatory Polysomnography (Psg) System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ambulatory Polysomnography (Psg) System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ambulatory Polysomnography (Psg) System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ambulatory Polysomnography (Psg) System Market by Type
  1. 4.1 Ambulatory Polysomnography (Psg) System Type Introduction
  2. 4.1.1 ＜10-Channel
  3. 4.1.2 ≥10-Channel
  4. 4.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Type
  5. 4.2.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Ambulatory Polysomnography (Psg) System Sales Value Share by Type (2021-2032)
5 Ambulatory Polysomnography (Psg) System Market by Application
  1. 5.1 Ambulatory Polysomnography (Psg) System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Home
  4. 5.1.3 Others
  5. 5.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Application
  6. 5.2.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ambulatory Polysomnography (Psg) System Sales Value Share by Application (2021-2032)
6 Ambulatory Polysomnography (Psg) System Regional Value Analysis
  1. 6.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ambulatory Polysomnography (Psg) System Sales Value (2021-2032)
  7. 6.3.2 North America Ambulatory Polysomnography (Psg) System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ambulatory Polysomnography (Psg) System Sales Value (2021-2032)
  10. 6.4.2 Europe Ambulatory Polysomnography (Psg) System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ambulatory Polysomnography (Psg) System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ambulatory Polysomnography (Psg) System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ambulatory Polysomnography (Psg) System Sales Value (2021-2032)
  16. 6.6.2 South America Ambulatory Polysomnography (Psg) System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ambulatory Polysomnography (Psg) System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ambulatory Polysomnography (Psg) System Sales Value Share by Country, 2025 VS 2032
7 Ambulatory Polysomnography (Psg) System Country-level Value Analysis
  1. 7.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ambulatory Polysomnography (Psg) System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ambulatory Polysomnography (Psg) System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ambulatory Polysomnography (Psg) System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ambulatory Polysomnography (Psg) System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ambulatory Polysomnography (Psg) System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Natus Embla
  2. 8.1.1 Natus Embla Company Information
  3. 8.1.2 Natus Embla Business Overview
  4. 8.1.3 Natus Embla Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Natus Embla Ambulatory Polysomnography (Psg) System Product Portfolio
  6. 8.1.5 Natus Embla Recent Developments
  7. 8.2 Compumedics
  8. 8.2.1 Compumedics Company Information
  9. 8.2.2 Compumedics Business Overview
  10. 8.2.3 Compumedics Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Compumedics Ambulatory Polysomnography (Psg) System Product Portfolio
  12. 8.2.5 Compumedics Recent Developments
  13. 8.3 Neurosoft
  14. 8.3.1 Neurosoft Company Information
  15. 8.3.2 Neurosoft Business Overview
  16. 8.3.3 Neurosoft Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Neurosoft Ambulatory Polysomnography (Psg) System Product Portfolio
  18. 8.3.5 Neurosoft Recent Developments
  19. 8.4 Cadwell Industries
  20. 8.4.1 Cadwell Industries Company Information
  21. 8.4.2 Cadwell Industries Business Overview
  22. 8.4.3 Cadwell Industries Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cadwell Industries Ambulatory Polysomnography (Psg) System Product Portfolio
  24. 8.4.5 Cadwell Industries Recent Developments
  25. 8.5 Philips
  26. 8.5.1 Philips Company Information
  27. 8.5.2 Philips Business Overview
  28. 8.5.3 Philips Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Philips Ambulatory Polysomnography (Psg) System Product Portfolio
  30. 8.5.5 Philips Recent Developments
  31. 8.6 Löwenstein Medical
  32. 8.6.1 Löwenstein Medical Company Information
  33. 8.6.2 Löwenstein Medical Business Overview
  34. 8.6.3 Löwenstein Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Löwenstein Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  36. 8.6.5 Löwenstein Medical Recent Developments
  37. 8.7 Nihon Kohden
  38. 8.7.1 Nihon Kohden Company Information
  39. 8.7.2 Nihon Kohden Business Overview
  40. 8.7.3 Nihon Kohden Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nihon Kohden Ambulatory Polysomnography (Psg) System Product Portfolio
  42. 8.7.5 Nihon Kohden Recent Developments
  43. 8.8 Nox Medical
  44. 8.8.1 Nox Medical Company Information
  45. 8.8.2 Nox Medical Business Overview
  46. 8.8.3 Nox Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nox Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  48. 8.8.5 Nox Medical Recent Developments
  49. 8.9 Somnomedics AG
  50. 8.9.1 Somnomedics AG Company Information
  51. 8.9.2 Somnomedics AG Business Overview
  52. 8.9.3 Somnomedics AG Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Somnomedics AG Ambulatory Polysomnography (Psg) System Product Portfolio
  54. 8.9.5 Somnomedics AG Recent Developments
  55. 8.10 Advanced Brain Monitoring (ABM)
  56. 8.10.1 Advanced Brain Monitoring (ABM) Company Information
  57. 8.10.2 Advanced Brain Monitoring (ABM) Business Overview
  58. 8.10.3 Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Advanced Brain Monitoring (ABM) Ambulatory Polysomnography (Psg) System Product Portfolio
  60. 8.10.5 Advanced Brain Monitoring (ABM) Recent Developments
  61. 8.11 DEYMED Diagnostic
  62. 8.11.1 DEYMED Diagnostic Company Information
  63. 8.11.2 DEYMED Diagnostic Business Overview
  64. 8.11.3 DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DEYMED Diagnostic Ambulatory Polysomnography (Psg) System Product Portfolio
  66. 8.11.5 DEYMED Diagnostic Recent Developments
  67. 8.12 Hangzhou NeuroTrace
  68. 8.12.1 Hangzhou NeuroTrace Company Information
  69. 8.12.2 Hangzhou NeuroTrace Business Overview
  70. 8.12.3 Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hangzhou NeuroTrace Ambulatory Polysomnography (Psg) System Product Portfolio
  72. 8.12.5 Hangzhou NeuroTrace Recent Developments
  73. 8.13 Beijing BMC Medical
  74. 8.13.1 Beijing BMC Medical Company Information
  75. 8.13.2 Beijing BMC Medical Business Overview
  76. 8.13.3 Beijing BMC Medical Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Beijing BMC Medical Ambulatory Polysomnography (Psg) System Product Portfolio
  78. 8.13.5 Beijing BMC Medical Recent Developments
  79. 8.14 Hunan VentMed Medical Technology
  80. 8.14.1 Hunan VentMed Medical Technology Company Information
  81. 8.14.2 Hunan VentMed Medical Technology Business Overview
  82. 8.14.3 Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hunan VentMed Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
  84. 8.14.5 Hunan VentMed Medical Technology Recent Developments
  85. 8.15 Hangzhou Lucky Day Medical Technology
  86. 8.15.1 Hangzhou Lucky Day Medical Technology Company Information
  87. 8.15.2 Hangzhou Lucky Day Medical Technology Business Overview
  88. 8.15.3 Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hangzhou Lucky Day Medical Technology Ambulatory Polysomnography (Psg) System Product Portfolio
  90. 8.15.5 Hangzhou Lucky Day Medical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst